Release Date: 25/08/14 09:53 Summary: Suspension from Official Quotation - Annual Listing Fee Price Sensitive: Yes Download Document 35.64KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%